
Not in Barcelona? Book a meeting with our team to discuss your programs bioanalysis needs ➡️ buff.ly/MkMQeUU

Global contract research organization (CRO) providing specialty laboratory services to support the entire drug development cycle.

Not in Barcelona? Book a meeting with our team to discuss your programs bioanalysis needs ➡️ buff.ly/MkMQeUU

CellCarta is at the European Bioanalysis Forum! Great to share insights into the cutting edge of bioanalysis. If you missed our presentation, reach out learn more about how mass spectrometry enables quantitative biomarker comparisons of BCMA and M-protein in multiple myeloma.

Can't make the talk? Contact our team to learn how we manage biospecimens in clinical programs. buff.ly/MkMQeUU

Don't miss her on the panel with our partners at Slope on Monday at 12:15, discussing how biospecimens are managed throughout their lifecycle with perspectives from sponsors, sites, CROs and lab sites.

CellCarta's Simone Spears-Keigan is heading to Boston for the Biospecimen Operations & Biospecimen Management Summit!

Barcelona, we'll see you next week ☀️ Our team is attending the European Bioanalysis Forum, and bringing a presentation on Mass Spectrometry in Multiple Myeloma. Heading to Barcelona? Book a meeting to discuss bioanalysis in clinical programs ➡️ buff.ly/jhcixgQ

The CellCarta Team is at ACR Convergence this week! Don't miss the chance to discuss high sensitivity B-cell monitoring and assay design with Maude Boisvert (Abstract Number: 1918), and how we support programs from translation to CDx with Nick Dupuis and Simone Spears.

Our scientific experts are at #SITC2026 this week, sharing perspectives and insights on assays, immunotherapy response profiles, and implementing assays across our global infrastructure. Drop by the posters or Booth #711 to connect with our experts in Phoenix!

We have three excellent posters heading to #SITC2026 with the CellCarta team. We're excited to discuss how our scientists can accelerate your immunotherapy programs goals. Make sure to drop by the poster sessions on November 7, or visit Booth #711 to learn more!

Choosing the right biomarker and clinical strategy can be the difference between a promising therapy reaching patients or stalling before it gets there. For >25 years, CellCarta has brought scientific rigor to the full spectrum of biomarker development. buff.ly/tdP1mf9

3️⃣Highly Sensitive B-Cell Monitoring Following B-Cell-Depleting Therapies ➡️ buff.ly/EdkuKNP

2️⃣ Assessing Inter-instrument Flow Cytometer Alignment ➡️ buff.ly/WTx6sh0

Get the links here: 1️⃣ Housekeeping Proteins in Mass Spectrometry ➡️ buff.ly/qWLkocQ

Our flow cytometry and proteomics expertise was on show this week with posters at AAPS PHarmSci360 and the Australasian Cytometry Society.

The CellCarta Team is heading to SITC! This is a great opportunity to grab one-on-one time with the team and discover how our scientific experts develop and deploy assays to collect the critical information your program needs. Book a meeting here: buff.ly/PzN9xZH

Every October, Breast Cancer Awareness Month reminds us why our work is critically important. To the patients, caregivers, clinicians, and researchers committed to advancing therapeutics in breast cancer: thank you for the work you do. We are proud to support it.